Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Not The Friday
View:
Post by Bunge on Feb 26, 2021 11:38am

Not The Friday

This was not the Friday we were looking for.

User image
Comment by robertshaw on Feb 26, 2021 12:16pm
Blowjobjoe's bosses are working hard to get more cheapies. As the stupid management is still buying, I think we are ok.
Comment by ScienceFirst on Feb 26, 2021 3:03pm
Robertshaw is the stupid investor.
Comment by gebremeskel on Feb 26, 2021 6:50pm
Since management is stupid and they're buying, this is a clear sign for you to sell.
Comment by robertshaw on Feb 26, 2021 7:31pm
No, I am waiting for $10+ for the sake of Mcfarland's promising technology, but not for stupid management.
Comment by Jaro1977 on Feb 26, 2021 8:08pm
think like this; https://stockhouse.com/companies/bullboard?symbol=v.tlt&postid=32467544
Comment by robertshaw on Feb 26, 2021 8:14pm
Yes, I am with you to wait for $300+/share.
Comment by tamarindo1 on Feb 26, 2021 8:23pm
I had thought that I might have it placed in my will that all TLT shares should be equally shared between my children but stipulated that they must be held until they reached $10 per share.  Then I thought just to be safe, but with the same stipulation, held for my grandchildren on their coming of age..  Then I thought, no. Let's make it my great grandchildren.    
Comment by m8magic on Feb 26, 2021 11:48pm
..hahahaha
Comment by toade1313 on Feb 28, 2021 8:52am
Sad part is, I know Theralase will be sending me emails to participate in private placements long after St Peter has let me through the Golden gates.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250